ENTITY
Innovent Biologics Inc

Innovent Biologics Inc (1801 HK)

516
Analysis
Health CareChina
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
more
20 Jul 2025 10:05

HK Connect Flows Weekly (Jul 18th): Meituan, CCB, Alibaba, Ping An Insurance, Akeso, Tencent, Xiaomi

We analyzed the Hong Kong Connect Scheme for last week and highlighted flows for Meituan, CCB, Alibaba, Ping An Insurance, Akeso, Tencent, Xiaomi,...

Logo
751 Views
Share
17 Jul 2025 19:20

Quiddity Leaderboard Hang Seng Biotech Sep25: 20 Deletions Likely Due to Major Methodology Change

A recent methodology change will result in a drop in constituent count from 50 to 30. This would trigger 20 deletions. These expected DELs could...

Share
bullishPop Mart
17 Jul 2025 16:09

Quiddity Leaderboard HSCEI Sep25: Final Expectations; One Index Change Possible

Pop Mart (9992 HK) could replace J&T Global (1519 HK) in the HSCEI index in September 2025. If this change takes place, there could be one-way...

Share
14 Jul 2025 19:28

Ascentage Pharma Top-Up Placement - Past Deals Didn't Done Well, Stock up a Lot but Sector Is Strong

Ascentage Pharma Group Corp (6855 HK) (AP) aims to raise around US$196m via  top-up placement. In this note, we talk about the deal dynamics.

Logo
418 Views
Share
13 Jul 2025 10:10

HK Short Interest Weekly: Ali Health, CCB, Giant Biogene

We analyzed the latest HK SFC report for aggregate short position as of Jul 4th and highlight short interest changes in Ali Health, CCB, Giant...

Logo
436 Views
Share
x